Back    Zoom +    Zoom -
CN Improves Drug Pricing Formation Mechanism to Optimize Initial Pricing for Innovative Drugs
Recommend
28
Positive
58
Negative
13
The General Office of China's State Council has issued its opinions on improving the drug pricing formation mechanism, stating that it will refine pricing policies for key segments at different stages after a drug's launch.

The opinions also proposed measures including optimizing the initial pricing mechanism for innovative and other newly launched drugs, leveraging medical insurance payment standards to guide drug price formation, improving the pricing mechanism for centralized volume-based drug procurement, and enhancing the management of listed online drug prices.

Related News UBS Upgrades MICROPORT MEDBOT (02252.HK) to Buy on Strong Overseas Sales, Expects Breakeven in 1H26


Auto-translated by AI

AASTOCKS Financial News